Replimune Group, Inc. (REPL) has a market capitalization of $161.02M and trades at $1.95. The 52-week range is 2.68-13.24.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-3.07.
The stock has a beta of 0.74, operates in the Healthcare sector.
